
Keywords: Hybrid molecules; Anti-fungal; Anti-tubercular; Anti-malarial; anti-inflammatory; ACTs; artemesinin based combination therapy; CQ; chloroquine; CC50; concentration required to reduce growth by 50%; EC50; half maximal effective concentration; Fqa; ferroqui